These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 30953353)
1. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice. Ichise T; Yoshida N; Ichise H J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353 [TBL] [Abstract][Full Text] [Related]
2. Making sense of Cbp/p300 loss of function mutations in skin tumorigenesis. Anastasi S; Alemà S; Segatto O J Pathol; 2020 Jan; 250(1):3-6. PubMed ID: 31397888 [TBL] [Abstract][Full Text] [Related]
3. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis. Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654 [TBL] [Abstract][Full Text] [Related]
4. Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways. Kasper LH; Thomas MC; Zambetti GP; Brindle PK Cell Cycle; 2011 Jan; 10(2):212-21. PubMed ID: 21220944 [TBL] [Abstract][Full Text] [Related]
5. Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer. Choo N; Keerthikumar S; Ramm S; Ashikari D; Teng L; Niranjan B; Hedwards S; Porter LH; Goode DL; Simpson KJ; Taylor RA; Risbridger GP; Lawrence MG J Pathol; 2024 Jun; 263(2):242-256. PubMed ID: 38578195 [TBL] [Abstract][Full Text] [Related]
6. The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. Wong CK; Wade-Vallance AK; Luciani DS; Brindle PK; Lynn FC; Gibson WT Diabetes; 2018 Mar; 67(3):412-422. PubMed ID: 29217654 [TBL] [Abstract][Full Text] [Related]
7. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189 [TBL] [Abstract][Full Text] [Related]
8. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression. Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525 [TBL] [Abstract][Full Text] [Related]
9. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression. Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053 [TBL] [Abstract][Full Text] [Related]
10. Tumor immune escape by the loss of homeostatic chemokine expression. Pivarcsi A; Müller A; Hippe A; Rieker J; van Lierop A; Steinhoff M; Seeliger S; Kubitza R; Pippirs U; Meller S; Gerber PA; Liersch R; Buenemann E; Sonkoly E; Wiesner U; Hoffmann TK; Schneider L; Piekorz R; Enderlein E; Reifenberger J; Rohr UP; Haas R; Boukamp P; Haase I; Nürnberg B; Ruzicka T; Zlotnik A; Homey B Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19055-60. PubMed ID: 18025475 [TBL] [Abstract][Full Text] [Related]
11. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017 [TBL] [Abstract][Full Text] [Related]
12. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688 [TBL] [Abstract][Full Text] [Related]
13. IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Liu B; Xia X; Zhu F; Park E; Carbajal S; Kiguchi K; DiGiovanni J; Fischer SM; Hu Y Cancer Cell; 2008 Sep; 14(3):212-25. PubMed ID: 18772111 [TBL] [Abstract][Full Text] [Related]
14. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins. Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306 [TBL] [Abstract][Full Text] [Related]
15. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Iglesias M; Frontelo P; Gamallo C; Quintanilla M Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574 [TBL] [Abstract][Full Text] [Related]
16. Cytoskeleton protein 4.1R suppresses murine keratinocyte cell hyperproliferation via activating the Akt/ERK pathway in an EGFR-dependent manner. Chen L; Wang T; Ji X; Ding C; Liang T; Liu X; Lu J; Guo X; Kang Q; Ji Z Exp Cell Res; 2019 Nov; 384(2):111648. PubMed ID: 31562860 [TBL] [Abstract][Full Text] [Related]
17. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity. Kramer D; Schön M; Bayerlová M; Bleckmann A; Schön MP; Zörnig M; Dobbelstein M Cell Death Dis; 2015 Feb; 6(2):e1634. PubMed ID: 25675294 [TBL] [Abstract][Full Text] [Related]
18. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells. Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677 [TBL] [Abstract][Full Text] [Related]
20. Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Wright LN; Ryscavage A; Merlino G; Yuspa SH Clin Cancer Res; 2012 Jan; 18(1):170-83. PubMed ID: 22068661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]